Trial site
University Hospital Graz
- 16running trials
- 8closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Childhood cancers2 trials
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Obesity2 trials
- Prostate cancer2 trials
- Alzheimer disease1 trial
- Asthma1 trial
- Atopic dermatitis (eczema)1 trial
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- and 17 more
- Phase
- Phase 319 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed8 trials
- Active, not recruiting7 trials
- Recruiting6 trials
- Not yet recruiting3 trials
- Suspended1 trial
- Lead sponsor
- AstraZeneca2 trials
- Actelion1 trial
- Amgen1 trial
- Aragon Pharmaceuticals, Inc.1 trial
- Boehringer Ingelheim1 trial
- and 19 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Active, not recruiting
Recruiting
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
Recruiting
Recruiting
Active, not recruiting
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Image-Verapamil SR in Adults with Type 1 Diabetes (Image-VER-A-T1D)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer2 recruiting
- Lung cancer2 recruiting
- Alzheimer disease1 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Glioblastoma1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Polycystic kidney disease1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Completed
Active, not recruiting
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Site data: ClinicalTrials.govUpdated 15 Nov 2026